Charles River Laboratories International Inc CRL

Morningstar Rating
$290.19 +3.36 (1.17%)
View Full Chart

Company Report

Price vs Fair Value

CRL is trading at a LOCK|b%hJWN premium.
Price
$286.83
Fair Value
LOCK|yn
Uncertainty
LOCK|K^
1-Star Price
LOCK|c.?$
5-Star Price
Lx
Economic Moat
LOCK|V!
Capital Allocation
LOCK|<@Yhyf

Bulls Say, Bears Say

Bulls

Charles River can leverage its scientific expertise and customer relationships as it rolls out non‑animal testing modalities as regulatory standards evolve.

Bears

The FDA’s roadmap to reduce animal testing, combined with advances in AI models, organoids, and cell-based assays, threatens the long-term demand and pricing power of Charles River’s core animal-models business.

News

Trading Information

Previous Close Price
$286.83
Day Range
$285.75–290.61
52-Week Range
$146.20–303.31
Bid/Ask
$290.00 / $295.00
Shares Outstanding
47.74M
Market Cap
$13.85B
Volume/Avg
445,516 / 921,125

Key Statistics

Price/Earnings (Normalized)
28.97
Price/Sales
3.50
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
2.34%

Company Profile

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
19,700

Competitors

Valuation

Metric
CRL
FTRE
LH
Price/Earnings (Normalized)
28.97145.1217.42
Price/Book Value
4.823.522.86
Price/Sales
3.500.671.76
Price/Cash Flow
20.4034.5310.88
Price/Earnings
CRL
FTRE
LH

Financial Strength

Metric
CRL
FTRE
LH
Quick Ratio
0.800.851.25
Current Ratio
1.350.961.80
Interest Coverage
−0.770.086.43
Quick Ratio
CRL
FTRE
LH

Profitability

Metric
CRL
FTRE
LH
Return on Assets (Normalized)
6.50%2.15%6.57%
Return on Equity (Normalized)
15.51%10.56%14.08%
Return on Invested Capital (Normalized)
9.46%7.32%9.11%
Return on Assets
CRL
FTRE
LH

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|R<@CyCzWLOCK|@T$242B
Danaher Corp
DHR
LOCK|Mztd<?d&LOCK|Dv$150B
Agilent Technologies Inc
A
LOCK|$Kmx?G&VLOCK|%&>$47B
IQVIA Holdings Inc
IQV
LOCK|f@>rrtLOCK|H&sy$43B
Waters Corp
WAT
LOCK|HVcyLWLOCK|@#b$42B
Illumina Inc
ILMN
LOCK|$@VS<>LOCK|c>!J^$41B
IDEXX Laboratories Inc
IDXX
LOCK|DhG@n!DLOCK|^V%$41B
Mettler-Toledo International Inc
MTD
LOCK|nTL^#n#%LOCK|<@&%$30B
Quest Diagnostics Inc
DGX
LOCK|YQvfjwLOCK|bW^%T$26B
Labcorp Holdings Inc
LH
LOCK|$ssZ&<@%LOCK|^L%cG$25B

Sponsor Center